Found 80 matching trials
Venetoclax Plus CACAG Regimen for Newly Diagnosed Acute Myeloid Leukemia PHASE2 The purpose of this study is to compare the efficacy and safety of venetocl...
Show More Location
Chinese PLA General Hospital
Learn More & Join Trial
A PALG Prospective Multicenter Clinical Trial to Compare the Efficacy of Two Standard Induction Therapies (DA-90 vs DAC) and Two Standard Salvage Regimens (FLAG-IDA vs CLAG-M) in AML Patients ≤ 60 Years Old PHASE3 The study will include newly-diagnosed AML patients, not suffering acute pr...
Show More Location
Weill Cornell Medicine
Learn More & Join Trial
Everolimus MICE-regimen in Treating Older Patients With Newly Diagnosed Acute Myeloid Leukemia PHASE1 RATIONALE: Drugs used in chemotherapy, such as mitoxantrone hydrochloride, ...
Show More Location
Ematologia con trapianto- AOU Policlinico Consorziale di Bari
Learn More & Join Trial
A Remission Induction Therapy and Risk-oriented Postremission Strategy for Adult Acute Myelogenous Leukemia (AML) PHASE3 The study was set up to assess:
1. Standard-dose versus high-dose remissio...
Show More Location
Dipartimento di Ematologia e Medicina Trasfusionale - Azienda Osp. Nazionale Santi Antonio e Biagio e Cesare Arrigo
Learn More & Join Trial
Precision Diagnosis Directing HDACi Chidamide Target Therapy for Adult T-LBL/ALL PHASE2 Based on the pediatric-inspired, PEG-L-asparaginase-intensified and MRD-dir...
Show More Location
Department of Hematology, Nanfang Hospital
Learn More & Join Trial
Clinical Study Protocol of IAV-induced Remission Followed by Consolidation Therapy With MDCyta+Ven in ND-AML NA This study evaluates the efficacy and safety of the combination of idarubic...
Show More Location
The First Affiliated Hospital with Nanjing Medical University
Learn More & Join Trial
AML-02: Omacetaxine With Standard-of-Care Induction With Cytarabine & Idarubicin in Newly-Diagnosed AML Patients PHASE1 This is a dose escalation study to evaluate Omacetaxine when given in combi...
Show More Location
University of Illinois at Chicago
Learn More & Join Trial
Phase 1 Study of Chemotherapy Plus HLA-mismatched GPBMC Infusion Bridging to Allo-HSCT for R/R Leukemia PHASE1 This is a Phase 1 clinical study designed to evaluate the safety, tolerabil...
Show More Location
Department of Hematology, the Fifth Medical Center of Chinese PLA General Hospital
Learn More & Join Trial
Idarubicin Plus Cytarabine (IA) vs IA Plus Cladribine (IAC) as Induction Regimen to Treat Initially Diagnosed Acute Myeloid Leukemia (AML) PHASE3 The goal of this clinical trial is to compare the clinical efficacy and saf...
Show More Location
The First Affiliated Hospital of Soochow University
Learn More & Join Trial
A Randomized Trial of a Combination of Nintedanib/Placebo in Combination With Induction Chemotherapy for Patients With Refractory or First Relapse Acute Myeloid Leukemia PHASE2 The purpose of this study is to determine if a combination of nintedanib+ i...
Show More Learn More & Join Trial